The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
After finishing at $10.22 in the prior trading day, Amicus Therapeutics Inc (NASDAQ: FOLD) closed at $10.04, down -1.76%. In other words, the price has decreased by -$1.76 from its previous closing price. On the day, 2.61 million shares were traded. FOLD stock price reached its highest trading level at $10.32 during the session, while it also had its lowest trading level at $10.005.
Ratios:
Our goal is to gain a better understanding of FOLD by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.26 and its Current Ratio is at 2.75. In the meantime, Its Debt-to-Equity ratio is 3.35 whereas as Long-Term Debt/Eq ratio is at 3.29.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Jefferies on September 06, 2024, initiated with a Buy rating and assigned the stock a target price of $18.
On May 30, 2024, Wells Fargo started tracking the stock assigning a Overweight rating and target price of $18.
Guggenheim Upgraded its Neutral to Buy on May 14, 2024, while the target price for the stock was maintained at $13.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Oct 01 ’24 when Campbell Bradley L sold 7,500 shares for $10.60 per share. The transaction valued at 79,492 led to the insider holds 886,654 shares of the business.
BRADLEY CAMPBELL bought 7,500 shares of FOLD for $80,100 on Oct 01 ’24. On Sep 03 ’24, another insider, Campbell Bradley L, who serves as the President and CEO of the company, sold 7,500 shares for $11.71 each. As a result, the insider received 87,798 and left with 886,654 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, FOLD now has a Market Capitalization of 2977773824 and an Enterprise Value of 3161768960. For the stock, the TTM Price-to-Sale (P/S) ratio is 6.54 while its Price-to-Book (P/B) ratio in mrq is 22.46. Its current Enterprise Value per Revenue stands at 6.939 whereas that against EBITDA is -189.52.
Stock Price History:
Over the past 52 weeks, FOLD has reached a high of $14.57, while it has fallen to a 52-week low of $9.02. The 50-Day Moving Average of the stock is -9.37%, while the 200-Day Moving Average is calculated to be -11.56%.
Shares Statistics:
The stock has traded on average 2.57M shares per day over the past 3-months and 2131050 shares per day over the last 10 days, according to various share statistics. A total of 293.59M shares are outstanding, with a floating share count of 289.03M. Insiders hold about 2.55% of the company’s shares, while institutions hold 105.21% stake in the company. Shares short for FOLD as of 1726185600 were 22808015 with a Short Ratio of 8.89, compared to 1723680000 on 24042394. Therefore, it implies a Short% of Shares Outstanding of 22808015 and a Short% of Float of 7.739999999999999.
